用环素控制二次焦点细分球粒样硬化中的蛋白尿:一个病例报告
Sohrab Kharabaf1, Matthew Nguyen1, Dao Le2
1School of Medicine, University of California, Irvine, CA, USA.
在患有与肥胖相关的二次焦点细分血球硬化症 (FSGS) 的年轻男性中,环素治疗显著降低了蛋白尿. 这表明,当其他疗法失败时,环素可能是FSGS的可行的治疗选择.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
背景情况:
- 焦点细分性淋巴细胞硬化症 (FSGS) 是一种导致蛋白尿和衰退的病.
- 二次性FSGS,通常与肥胖或遗传因素有关,缺乏标准化治疗.
- 与肥胖相关的过会导致FSGS的发病.
更多相关视频
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Chronic Kidney Disease III: Interprofessional Care
Nephrotic Syndrome I : Introduction
Kidney Transplant II: Surgical Procedure
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
